A 26-kilogram radiation-shielding plastic garment named AstroRad, tested on a model human torso during NASA’s uncrewed Artemis I mission, could reduce astronaut radiation exposure during a major solar storm by up to 60 percent, according to a recent analysis of flight data published by Jordan Houri and colleagues.
Operating beyond Earth’s magnetosphere exposes space crews to unique hazards. While chronic background radiation poses long-term concerns, intense bursts of solar radiation known as solar particle events can deliver dangerous doses in just hours. Historical benchmarks like the August 1972 and October 1989 solar particle events highlight the severe risks deep-space crews face, making personal protective equipment a critical focus for agencies like NASA, the Israel Space Agency, and aerospace partner Lockheed Martin.
In Plain English: The Clinical Takeaway
- Targeted Protection: The AstroRad vest shields specific high-risk areas—such as bone marrow, breasts, and ovaries—rather than the entire body, maximizing defense for radiation-sensitive organs.
- Hydrogen-Rich Material: Built from high-density polyethylene, the vest uses hydrogen-dense plastic to block incoming space particles without triggering secondary neutron sprays associated with heavy metals like lead.
- Historical Validation: Data extrapolated from the Orion spacecraft’s passage through the Inner Van Allen belt indicates the vest would have cut historical solar storm radiation doses by 40 to 60 percent.
Clinical Mechanics: How the AstroRad Vest Shields Vital Tissues
Space radiation consists of galactic cosmic rays and unpredictable solar particle events. Traditional heavy metals like lead are effective against terrestrial X-rays and gamma rays, but they perform poorly against high-energy particles in space. When beta particles or neutrons strike lead atoms, they can trigger secondary particle showers that worsen tissue damage. StemRad designed the AstroRad vest to avoid this pitfall by utilizing a high-density, hydrogen-rich plastic core.
Hydrogen possesses the highest density of electrons per atom among elements, creating a formidable barrier against incoming charged particles. Furthermore, because hydrogen atoms typically lack neutrons, they do not generate dangerous neutron scatter upon impact. The vest’s creators assembled thousands of hexagonal rods of rigid plastic into a flexible, scale-like garment weighing approximately 57 pounds (26 kilograms). This design strategy delivers about a 30 percent greater reduction in radiation dose to targeted tissues compared to distributing the same shielding uniformly across a full-body suit.
Evaluating Historical Benchmarks and Phantom Trials
Because the Artemis I mission did not encounter an active solar particle event during flight, researchers quantified the vest’s efficacy by measuring radiation received while passing through the Inner Van Allen belt. They tested the data using two sophisticated female torso phantoms named Zohar and Helga, equipped with more than 5,600 internal and external dosimeters. Zohar wore the AstroRad vest, while Helga remained unprotected, allowing scientists to directly compare exposure levels.
When researchers applied these findings to historical solar storms, the results demonstrated substantial risk reduction. For the August 1972 solar particle event, the vest reduced exposure by approximately 60 percent—equivalent to sparing an astronaut 193 days of continuous deep-space radiation. For the October 1989 event, the reduction reached approximately 40 percent, sparing the equivalent of 131 days of continuous exposure.
| Solar Storm Benchmark | Estimated Dose Reduction | Equivalent Days of Deep Space Radiation Spared |
|---|---|---|
| August 1972 Solar Particle Event | Approx. 60 percent | 193 days |
| October 1989 Solar Particle Event | Approx. 40 percent | 131 days |
Funding, Development, and Future Artemis Operations
The development of the AstroRad vest was led by the Israeli startup StemRad, with foundational support from the Israel Space Agency and aerospace contractor Lockheed Martin. As NASA advances from the uncrewed Artemis I flight to crewed missions under Artemis II and lunar landing objectives for Artemis III, mitigating radiation-induced cancer risks transitions from theoretical modeling to operational necessity.
“Radiation in space is unavoidable, and a single major solar particle event can make a substantial contribution to an astronaut’s lifetime risk of radiation-induced cancer,” noted Oren Milstein, CEO and co-founder of StemRad. With personal shielding now validated through rigorous flight data, space agencies have a concrete technological tool to safeguard human crews venturing back to the Moon and onward to Mars.
Contraindications & When to Consult a Doctor
The Takeaway
The successful testing of the AstroRad vest on Artemis I marks a significant milestone in spaceflight medicine. By combining targeted organ shielding with hydrogen-dense materials, researchers have established a viable protocol to protect astronauts from unpredictable solar particle events. As Artemis missions progress toward crewed lunar landings, such innovations will be vital for preserving long-term crew health in deep space.
Worth a look
- Madagascar Healthcare Donation Supports Universal Health Coverage
- FDA Recall: Frankie’s Organic Vegan Cheddar Puffs Recalled for Undeclared Milk
- Severe Storms and Hail Forecast for Denver, Colorado (news-usa.today)
- Solar Eclipse 2026: Crowds Queue in Dublin as Excitement Builds for Rare Event (archynewsy.com)
